Sign In
Buy KLYG
$0.126
-0.0095 (-6.98%)
At Close: Jun 03, 2026
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
01:00am, Monday, 01'st Jun 2026
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader PR Newswire
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
12:01am, Monday, 01'st Jun 2026
COLLINSVILLE, Conn., June 1, 2026 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leader in patient-specific cranial and craniofacial implants, today announced it will present at the Planet Micro
Kelyniam Global Announces Strong Q1 2026 Financial Results
12:01am, Monday, 11'th May 2026
CANTON, Conn., May 11, 2026 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a leader in custom cranial implants, today reported its financial results for the first quarter ended March 31, 2026.
Kelyniam Global Reports 2025 Financial Results
12:01am, Monday, 16'th Mar 2026
Strong Second-Half Momentum Drives 85% Net Loss Improvement; FDA Clearance Secured for Innovative Fusion™ Biomaterial Implant; Board Rejects Undervalued Acquisition Interest CANTON, Conn., March 16,
Kelyniam Global Announces Q3 2025 Financial Results
03:55pm, Monday, 10'th Nov 2025
CANTON, Conn. , Nov. 10, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today reported financial results for the third quarter ended Sep
Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products
07:09pm, Thursday, 06'th Nov 2025
CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licen
Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant
11:23am, Thursday, 18'th Sep 2025
CANTON, Conn. , Sept. 18, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (Kelyniam), a leading provider of custom cranial and craniofacial implant solutions, announced today that it has received 510(k) cl
Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th
12:01am, Monday, 15'th Sep 2025
The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com CANTON, Conn. , Sept. 15, 2025 /PRNewswire/ -- Kelyn
Commitment to Investor
12:01am, Monday, 08'th Sep 2025
Excellence Kelyniam Global, Inc. Uplists to OTCID Market Tier CANTON, Conn. , Sept. 8, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial
Kelyniam Global Announces Q2 2025 Financial Results
11:16am, Monday, 11'th Aug 2025
CANTON, Conn. , Aug. 11, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the half
Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership
12:00am, Monday, 12'th May 2025
CANTON, Conn. , May 12, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first
KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024
12:00am, Monday, 17'th Mar 2025
CANTON, Conn. , March 17, 2025 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a manufacturer of custom cranial implants, has announced its financial results for the year ended December 31, 2024.
Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering
12:01am, Monday, 16'th Dec 2024
Proceeds to Further Growth Objectives in 2025 CANTON, Conn. , Dec. 16, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced that it has completed the s
Kelyniam Global Releases Q3 Financials, Strong Performance Continues
12:01am, Monday, 11'th Nov 2024
CANTON, Conn. , Nov. 11, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for the third quarter ended September 30, 2024.
Kelyniam Global Releases Strong Q2 Financials
12:02am, Monday, 12'th Aug 2024
CANTON, Conn. , Aug. 12, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its half year ended June 30, 2024.
